DCF — CARY MEDICAL CENTER
Enterprise Value: $-104.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-104.6M
Enterprise Value
$-33.0M
PV of Cash Flows
$-71.7M
PV of Terminal Value
$-115.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $61.3M | $-6.6M | -11.0% | $-9.2M | $-8.4M |
| Year 2 | $63.1M | $-6.2M | -10.0% | $-8.8M | $-7.3M |
| Year 3 | $65.0M | $-5.7M | -9.0% | $-8.4M | $-6.3M |
| Year 4 | $66.9M | $-5.5M | -8.0% | $-8.4M | $-5.7M |
| Year 5 | $68.9M | $-5.5M | -8.0% | $-8.4M | $-5.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-104.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$59.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11269191974021428
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5